Showing results (41-50 of 375) with videos related to

Sort By:
Pageof 38
Diagnostics (Basel, Switzerland)|July 14, 2023
Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine NeoplasmsAadil Adnan, Sandip Basu
Clinical Nuclear Medicine|May 4, 2026
Prostate-specific Membrane Antigen-PET/CT in Nonprostatic Malignancies: Potential Applications in TheranosticsPriyanka Verma, Sandip Basu
Indian Journal of Cancer|April 5, 2005
(18)FDG PET in primary oat cell carcinoma of the esophagusSandip Basu, Narendra Nair
Journal of Nuclear Medicine Technology|September 5, 2015
18F-FDG PET/CT Prediction of an Aggressive Clinical Course for Dermatofibrosarcoma ProtuberansSandip Basu, Fahim Goliwale
Journal of Nuclear Medicine Technology|August 15, 2015
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar DegenerationPradeep Thapa, Sandip Basu
Cancer Biotherapy & Radiopharmaceuticals|April 20, 2016
Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?Bhakti Basu, Sandip Basu
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 5, 2019
Leveraging the power of non-radium radionuclide treatments in bone metastasesPradeep Thapa, Sandip Basu
Nuclear Medicine Review. Central & Eastern Europe|June 26, 2009
Revolutionary impact of PET and PET-CT on the day-to-day practice of medicine and its great potential for improving future health careSandip Basu, Abass Alavi
World Journal of Nuclear Medicine|May 30, 2017
Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's SyndromeChinna Naik, Sandip Basu
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 13, 2018
Discordant Primary Resistance to Imatinib Mesylate in the Same Individual and Splenic Involvement in Recurring Gastric Gastrointestinal Stromal Tumors: Assessment by Fluorodeoxyglucose-Positron Emission Tomography/Computed TomographyPreeti Fargose, Sandip Basu
Pageof 38